22nd Jun 2006 17:43
Protherics PLC22 June 2006 PROTHERICS PLC NOTIFICATION OF MAJOR INTERESTS IN SHARES 22 June 2006: Protherics PLC, the biopharmaceutical company focused on criticalcare and oncology (the "Company"), received notification from Aviva plc on 21June 2006 that, as at 20 June 2006, Aviva plc and its subsidiaries held aninterest in 29,061,225 ordinary shares, representing 11.16% of the issued sharecapital of the Company. The Shares are represented by a beneficial interest in 12,144,826 ordinaryshares (4.66%) and a non-beneficial interest in 16,916,399 ordinary shares(6.50%). This notification follows the purchase of 540,367 ordinary shares representing0.21% of the issued share capital of the Company. The issued share capital of the Company is 260,295,464 ordinary shares. ENDS For further information contact: Protherics PLC +44 (0) 20 7246 9950Julie Vickers, Company Secretary +44 (0) 1928 518010Nick Staples, Corporate Affairs +44 (0) 7919 480510 (mobile) Financial Dynamics +44 (0) 20 7831 3113Ben Atwell/David Yates This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Aviva